Teva Pharmaceutical Industries Limited

NYSE: TEVA
Share price (12/20/24): $22.09
Market cap (12/20/24): $25.0 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of ADR shares, immediately effective

Prospectus supplement for primary offering

Ownership Filter

Bridger Management, LLC

Lichtenstein Chen

Lichtenstein Chen

News Filter

Change in Directors, Officers or Compensation

Announces Strong Financial Results for the Third Quarter of 2024, Led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook Including on Revenues, Adjusted EBITDA and Non-Gaap EPS

Announces Strong Growth in Second Quarter Revenues Mainly Driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance

Material Definitive Agreement

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Conflict Minerals disclosure

Letter from the SEC

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC